AccessibilityHelpAbout Us
Sanofi logo

Sanofi(OTC) SNYNF

Market Cap$100.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)+52%
5 Year+5%
1 Year-6%
1 Month-4%
$84.02
-3.78%
-3.30Today
Sanofi last closing stock price
MetricPriceDate
Last closeUSD 84.022026-09-11
Sanofi stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.88%USD 89.272026-09-04
1 month-3.54%USD 87.102026-08-12
3 month-5.12%USD 88.552026-06-12
Year to date-8.45%USD 91.782025-12-31
1 year-5.64%USD 89.052025-09-11
3 year-11.6%USD 95.052023-09-12
5 year+4.86%USD 80.132021-09-10
Since inception+51.54%USD 55.442003-06-27

Sanofi Financials at a Glance

Market Cap

$100.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€60.44B

Net Income (TTM)

€6.76B

EPS (TTM)

$3.88

P/E Ratio

21.54

Dividend

$4.84

Beta (Volatility)

0.02 (Low)

Price

$84.02

Volume

137

Open

$86.81

Previous Close

$84.02

Daily Range

$84.02 - $86.81

52-Week Range

$80.74 - $106.34

Estimated Earnings Date

Oct 30, 2026

SNYNF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sanofi

Sanofi is a global healthcare company focused on research, development, manufacturing, and marketing of therapeutic solutions. The company specializes in immunology, rare diseases, neurology, oncology, and vaccines, aiming to improve patient outcomes worldwide.

Products and Services
  • Therapeutic solutions in immunology and oncology
  • Vaccines for various diseases, including pediatric vaccines
  • Collaborative projects for innovative drug development
Growth Outlook
  • Recent quarterly revenue reached €12.3 billion, indicating strong market demand
  • TTM net income of €3.4 billion reflects solid profitability
  • Strategic collaborations enhance innovation and market reach
Financial Highlights
  • Quarterly revenue of €12.3 billion, up from €11.2 billion in Q1
  • TTM dividend yield of 5.22%, showcasing attractive returns
  • Operating income margin of 19.38% demonstrates operational efficiency
Sanofi's diverse product portfolio and strategic collaborations position the company for sustained growth in the healthcare sector. The recent financial performance highlights a robust revenue stream and profitability, making it an appealing option for investors interested in the pharmaceutical industry. The company's commitment to innovation and patient care further strengthens its market presence and potential for future success.
AI Generated • Aug 22, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

76,493

CEO

Paul Hudson

Website

www.sanofi.com

Headquarters

Paris, IF 75017, FR

SNYNF Financials

Key Financial Metrics (TTM)

Gross Margin

72.77%

Operating Margin

20.58%

Net Income Margin

8.09%

Return on Equity

5.52%

Return on Capital

15.54%

Return on Assets

3.07%

Earnings Yield

4.64%

Dividend Yield

5.76%

Payout Ratio

1.24%

Stock Overview

Market Cap

$100.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.19B

Volume

137

Avg. Volume

42.00K

Financials (TTM)

Gross Profit

€43.71B

Operating Income

€15.68B

EBITDA

€13.79B

Operating Cash Flow

€17.26B

Capital Expenditure

-€790.93M

Free Cash Flow

€16.47B

Cash & ST Invst.

€6.35B

Total Debt

€23.58B

Sanofi Performance Analysis

Sanofi annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 45,188,742,6911.2%
20232023-12-31EUR 40,884,548,758-9.5%
20242024-12-31EUR 44,436,937,9608.7%
20252025-12-31EUR 49,235,341,67210.8%
Sanofi sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3022.7%
Q42025-12-3180.2%
Q12026-03-31-52.6%
Q22026-06-309.4%
Sanofi annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 7.0019.7%
20232023-12-31EUR 4.65-33.6%
20242024-12-31EUR 4.793.0%
20252025-12-31EUR 4.790.1%
Sanofi sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-28.8%
Q42025-12-31-26.9%
Q12026-03-31-19.3%
Q22026-06-30-78.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€12.30B

+14.6%

Gross Profit

€9.28B

+19.9%

Gross Margin

75.47%

N/A

Market Cap

$100.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.31M

N/A

Employees

76,493

N/A

Net Income

€343.00M

-91.3%

EBITDA

€1.68B

-11.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€6.35B

-58.7%

Total Debt

€23.58B

+5.8%

Accounts Receivable

€9.21B

+12.2%

Inventory

€24.12B

+150.8%

Long Term Debt

€16.32B

+10.9%

Short Term Debt

€7.25B

-4.1%

Return on Assets

3.07%

N/A

Return on Invested Capital

10.37%

N/A

Free Cash Flow

€3.34B

+55.7%

Operating Cash Flow

€4.64B

+29.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GSKGSK plc
$49.94+3.76%
SNYSanofi
$43.30+1.24%
BMYBristol-Myers Squibb Company
$64.12+0.75%
BAYRYBayer AG
$14.19+1.76%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$210.48-0.04%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$100.82-0.17%
NOKNokia
$9.87-0.11%
INTCIntel
$96.76-0.06%

Questions About SNYNF

What is the current price of Sanofi?

Sanofi is trading at $84.02 per share.

What is the 52-week range for Sanofi?

Over the past 52 weeks, Sanofi has traded between $80.74 and $106.34.

How much debt does Sanofi have?

As of the most recent reporting period, Sanofi reported total debt of €23.88B.

How much cash does Sanofi have on hand?

Sanofi reported €8.68B in cash and cash equivalents in its most recent financial results.

What is Sanofi’s dividend yield?

Sanofi currently has a dividend yield of 5.76%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services